Cambridge Investment Research Advisors, Inc. Assertio Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 19,034 shares of ASRT stock, worth $15,036. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,034
Previous 19,034
-0.0%
Holding current value
$15,036
Previous $12,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ASRT
# of Institutions
82Shares Held
26.9MCall Options Held
447KPut Options Held
76.3K-
Nantahala Capital Management, LLC New Canaan, CT8.81MShares$6.96 Million0.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$3.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.94MShares$2.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$807,5900.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $38.1M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...